Gene · 1495
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial. | Br J Cancer | 2024 | 37903909 | PubTator, text mining | PubMed |
| Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy. | J Clin Oncol | 2024 | 37903316 | PubTator, text mining | PubMed |
| Damaging Mutations in AFDN Contribute to Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate. | Cleft Palate Craniofac J | 2024 | 36384317 | PubTator, text mining | PubMed |
| Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent Subjects. | Eur J Respir Med | 2023 | 38390497 | PubTator, text mining | PubMed |
| Implementing an On-Slide Molecular Classification of Gastric Cancer: A Tissue Microarray Study. | Cancers (Basel) | 2023 | 38201483 | PubTator, text mining | PubMed |
| Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer. | eGastroenterology | 2023 | 38188186 | PubTator, text mining | PubMed |
| Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research. | Life (Basel) | 2023 | 38137912 | PubTator, text mining | PubMed |
| Landscape of Innovative Methods for Early Diagnosis of Gastric Cancer: A Systematic Review. | Diagnostics (Basel) | 2023 | 38132192 | PubTator, text mining | PubMed |
| Interplay of homologous-recombination genes and Helicobacter pylori in gastric cancer susceptibility. | Transl Cancer Res | 2023 | 38130304 | PubTator, text mining | PubMed |
| Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. | Mol Cancer | 2023 | 38111008 | PubTator, text mining | PubMed |
| Molecular basis and cellular functions of vinculin-actin directional catch bonding. | Nat Commun | 2023 | 38097542 | PubTator, text mining | PubMed |
| Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population. | Front Pharmacol | 2023 | 38074121 | PubTator, text mining | PubMed |
| Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. | Int J Mol Sci | 2023 | 38069284 | PubTator, text mining | PubMed |
| Tumor-suppressive functions of protein lysine methyltransferases. | Exp Mol Med | 2023 | 38036730 | PubTator, text mining | PubMed |
| Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers. | Heliyon | 2023 | 38027682 | PubTator, text mining | PubMed |
| Immunomodulation exerted by galectins: a land of opportunity in rare cancers. | Front Immunol | 2023 | 38022609 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. | Medicina (Kaunas) | 2023 | 38004002 | PubTator, text mining | PubMed |
| Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. | Cancers (Basel) | 2023 | 38001750 | PubTator, text mining | PubMed |
| Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype. | Nat Commun | 2023 | 37973922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1495/papers?page=5